tradingkey.logo
tradingkey.logo
Pesquisar

Zoetis Inc

ZTS
Adicionar à lista de desejos
71.400USD
-1.620-2.22%
Fechamento 09-18 16:00ET
29.59BValor de mercado
11.83P/L TTM
Após o expediente 19:00 (ET)71.400USD-0.140-0.20%

Mais detalhes de Zoetis Inc Empresa

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

Zoetis Inc Perfil

Código da empresaZTS
Nome da EmpresaZoetis Inc
Data de listagemFeb 01, 2013
CEOPeck (Kristin C)
Número de funcionários13800
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 01
Endereço10 Sylvan Way
CidadePARSIPPANY
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07054
Telefone19738227000
Sitehttps://www.zoetis.com/
Código da empresaZTS
Data de listagemFeb 01, 2013
CEOPeck (Kristin C)

Executivos da empresa Zoetis Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
28.39K
+42.72%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Mr. Frank A. D'Amelio
Mr. Frank A. D'Amelio
Independent Director
Independent Director
14.81K
-44.91%
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%
Ms. Vanessa Broadhurst
Ms. Vanessa Broadhurst
Independent Director
Independent Director
3.92K
--
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
3.73K
+0.72%
Mr. Keith Sarbaugh
Mr. Keith Sarbaugh
Executive Vice President, Chief Digital and Technology Officer
Executive Vice President, Chief Digital and Technology Officer
3.35K
+30.01%
Dr. Robert J. (Rob) Polzer, Ph.D.
Dr. Robert J. (Rob) Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
1.96K
-216.45%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
105.90K
+0.02%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
28.39K
+42.72%
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
18.17K
--
Mr. Frank A. D'Amelio
Mr. Frank A. D'Amelio
Independent Director
Independent Director
14.81K
-44.91%
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.71K
+9.15%

Perguntas frequentes

Quem são os cinco principais acionistas de Zoetis Inc?

Os cinco principais acionistas de Zoetis Inc são: Ms. Kristin C. Peck

Qual é a maior fonte de receita da Zoetis Inc?

Em 2026Q4, o segmento de negócios Parasiticides gerou a maior receita para Zoetis Inc, totalizando 698.00M e representando 28.28% da receita total.
tradingkey.logo
Aviso de risco: Nosso site e aplicativo móvel fornecem apenas informações gerais sobre determinados produtos de investimento. A Finsights não oferece, e o fornecimento de tais informações não deve ser interpretado como se a Finsights estivesse oferecendo, aconselhamento financeiro ou recomendação para qualquer produto de investimento.
Os produtos de investimento estão sujeitos a riscos significativos, incluindo a possível perda do valor investido e podem não ser adequados para todos. O desempenho passado dos produtos de investimento não é indicativo de seu desempenho futuro.
A Finsights pode permitir que anunciantes ou afiliados realizem, ou forneçam anúncios em nosso site, ou aplicativo móvel, ou em qualquer parte deles e pode ser compensada por eles com base em sua interação com os anúncios.
 © Copyright: FINSIGHTS MEDIA PTE. LTD. Todos os direitos reservados.